IgG4-Related Disease
Disease State Hub
Featured
12/18/2024
Miranda Manier, BA
In a phase 3 trial, inebilizumab, a monoclonal antibody targeting CD19+ B cells, reduced flare rates and improved treatment-free and glucocorticoid-free remission in patients with immunoglobulin G4-related...
12/18/2024
11/18/2024
Miranda Manier, BA
While pediatric and adult immunoglobulin G4-related disease share some similarities, there are important differences in how they present, especially in organ involvement and diagnostic criteria. Test your...
11/18/2024
11/08/2024
How familiar are you with the most common lung complication in immunoglobulin G4–related disease? Test your knowledge with this quiz to find out!
11/08/2024
Interactive Features
11/18/2024
Miranda Manier, BA
While pediatric and adult immunoglobulin G4-related disease share some similarities, there are important differences in how they present, especially in organ involvement and diagnostic criteria. Test your...
11/18/2024
11/08/2024
How familiar are you with the most common lung complication in immunoglobulin G4–related disease? Test your knowledge with this quiz to find out!
11/08/2024
10/30/2024
According to a recent review article, 58% of patients with immunoglobulin G4-related disease (IgG4-RD) had damage in at least one organ at diagnosis. Take this quiz to find out which organ is most often...
10/30/2024
11/22/2015
Researchers recently investigated inebilizumab as a potential treatment option for patients with immunoglobulin G4-related disease. Test your understanding of the findings!
11/22/2015
